Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine versus lidocaine for pain relief during perineal repair after childbirth
PACTR202501611433171Phase 4Not yet recruiting
- Sponsor
- Sanusi Akinsola Tesleem
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine and lidocaine in episiotomy and perineal laceration (2 arms), sponsored by Sanusi Akinsola Tesleem. Primary endpoints: Analgesic efficacy during perineal repair and postoperative follow-up and Participant satisfaction with pain control. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
bupivacainelidocaine
03
Conditions
episiotomyperineal laceration
Beyond the preview
Go deeper on PACTR202501611433171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501611433171.